<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - CLARITHROMYCIN</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>CLARITHROMYCIN</h1>

        <p><a href="../drugClass/PHP34517.html">MACROLIDES</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#professionSpecificInformation" data-toggle="tab">Profession specific information</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Respiratory-tract infections</span>,
                <span class="indication">Mild to moderate skin and soft-tissue infections</span>,
                <span class="indication">Otitis media</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                250 mg twice daily usually for 7&#8211;14 days, increased to 500 mg twice daily, if required in severe infections (e.g. pneumonia).</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg once daily usually for 7&#8211;14 days, increased to 1 g once daily, if required in severe infections (e.g. pneumonia).</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg every 12 hours maximum duration 5 days, switch to oral route when appropriate, to be administered into a large proximal vein.</li>
              <li class="dose child"><strong>For children 1 month&#8211;11 years (body-weight up to 8 kg)</strong><br/>
                7.5 mg/kg twice daily.</li>
              <li class="dose child"><strong>For children 1 month&#8211;11 years (body-weight 8&#8211;11 kg)</strong><br/>
                62.5 mg twice daily.</li>
              <li class="dose child"><strong>For children 1 month&#8211;11 years (body-weight 12&#8211;19 kg)</strong><br/>
                125 mg twice daily.</li>
              <li class="dose child"><strong>For children 1 month&#8211;11 years (body-weight 20&#8211;29 kg)</strong><br/>
                187.5 mg twice daily.</li>
              <li class="dose child"><strong>For children 1 month&#8211;11 years (body-weight 30&#8211;40 kg)</strong><br/>
                250 mg twice daily.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                250 mg twice daily usually for 7&#8211;14 days, increased to 500 mg twice daily, if required in severe infections (e.g. pneumonia).</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                500 mg once daily usually for 7&#8211;14 days, increased to 1 g once daily, if required in severe infections (e.g. pneumonia).</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Lyme disease</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg twice daily for 14&#8211;21 days.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                500 mg twice daily for 14&#8211;21 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prevention of pertussis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg twice daily for 7 days.</li>
              <li class="dose child"><strong>For children 1 month&#8211;11 years (body-weight up to 8 kg)</strong><br/>
                7.5 mg/kg twice daily for 7 days.</li>
              <li class="dose child"><strong>For children 1 month&#8211;11 years (body-weight 8&#8211;11 kg)</strong><br/>
                62.5 mg twice daily for 7 days.</li>
              <li class="dose child"><strong>For children 1 month&#8211;11 years (body-weight 12&#8211;19 kg)</strong><br/>
                125 mg twice daily for 7 days.</li>
              <li class="dose child"><strong>For children 1 month&#8211;11 years (body-weight 20&#8211;29 kg)</strong><br/>
                187.5 mg twice daily for 7 days.</li>
              <li class="dose child"><strong>For children 1 month&#8211;11 years (body-weight 30&#8211;40 kg)</strong><br/>
                250 mg twice daily for 7 days.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                500 mg twice daily for 7 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication"><ph outputclass="organism"> <i> <i>Helicobacter pylori</i> </i> </ph> eradication in combination with a proton pump inhibitor and amoxicillin</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg twice daily.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication"><ph outputclass="organism"> <i> <i>Helicobacter pylori</i> </i> </ph> eradication in combination with a proton pump inhibitor and metronidazole</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                250 mg twice daily.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <p>Manufacturer advises avoid, particularly in the first trimester, unless potential benefit outweighs risk.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="generalInformation">
              <p>Avoid in severe impairment if renal impairment also present.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

            <section class="doseAdjustments">
              <h3 class="specificity">In adults</h3>
              <p>Use half normal dose if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, max. duration 14 days.</p>
            </section>
            <section class="doseAdjustments">
              <h3 class="specificity">In children</h3>
              <p>Use half normal dose if estimated glomerular filtration rate less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, max. duration 14 days.</p>
            </section>
        
            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in adults</h3>
              <p>Avoid <i>Klaricid XL</i>
            <tm tmtype="reg"/> or clarithromycin m/r preparations if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>
            </section>
            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in children</h3>
              <p>Avoid <i>Klaricid XL</i>
            <tm tmtype="reg"/> or clarithromyin m/r preparations if estimated glomerular filtration rate less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>
            </section>
            <section class="generalInformation">
              <p>Avoid if severe hepatic impairment also present.</p>
            </section>
      </section>


      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

          <h3>General side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> Dyspepsia, headache, hyperhidrosis, insomnia, taste disturbances,
              </p>
              <p>
                <strong>uncommon:</strong> Anorexia, anxiety, blood disorders, chest pain, constipation, dizziness, dry mouth, flatulence, gastritis, glossitis, hepatic dysfunction including jaundice, leucopenia, malaise, myalgia, stomatitis, tinnitus, tremor,
              </p>
              <p>
                <strong>notKnown:</strong> Abnormal dreams, confusion, convulsions, depression, hypoglycaemia, interstitial nephritis, myopathy, paraesthesia, psychotic disorders, renal failure, smell disturbances, tongue discoloration, tooth discoloration,
              </p>
        
        
        
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in children</h3>
              <p>For intermittent intravenous infusion dilute reconstituted solution further in Glucose 5% <i>or</i> Sodium chloride 0.9% to a concentration of 2&#8239;mg/mL; give into large proximal vein over 60 minutes.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in adults</h3>
              <p>For <i>intravenous infusion</i> (<i>Klaricid</i>
            <tm tmtype="reg"/>
            <i>I.V.</i>), give intermittently in Glucose 5% or Sodium Chloride 0.9%; dissolve initially in water for injections (500&#8239;mg in 10&#8239;mL) then dilute to a concentration of 2&#8239;mg/mL; give over 60 minutes.</p>
            </section>
      </section>

      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="patientResources">
              <h3 class="specificity">In children</h3>
                <p class="title">Medicines for Children leaflet: Clarithromycin for bacterial infections</p>
              <p>
            <xref format="html" href="http://www.medicinesforchildren.org.uk/clarithromycin-bacterial-infections">www.medicinesforchildren.org.uk/clarithromycin-bacterial-infections</xref>
            </p>
            </section>
      </section>






      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in children</h3>
              <p>Tablets not licensed for use in children under 12 years; oral suspension not licensed for use in infants under 6 months.</p>
            </section>
            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in children</h3>
              <p>Intravenous infusion not licensed for use in children under 12 years.</p>
            </section>
      </section>







      <section class="tab-pane" id="professionSpecificInformation">
        <h2>Profession specific information</h2>

          <h3>Dental practitioners</h3>
        
            <section class="dentalPractitionersFormulary">
              <p>Clarithromycin Tablets may be prescribed.</p>
            </section>
            <section class="dentalPractitionersFormulary">
              <p>Clarithromycin Oral Suspension may be prescribed.</p>
            </section>
      </section>



      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of CLARITHROMYCIN</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            eye drops,
            infusion,

            <div id="PHP75593"><a href="../medicinalForm/PHP75593.html" data-target="#PHP75593" data-action="load">Tablet</a></div>
            <div id="PHP75586"><a href="../medicinalForm/PHP75586.html" data-target="#PHP75586" data-action="load">Modified-release tablet</a></div>
            <div id="PHP75614"><a href="../medicinalForm/PHP75614.html" data-target="#PHP75614" data-action="load">Granules</a></div>
            <div id="PHP75600"><a href="../medicinalForm/PHP75600.html" data-target="#PHP75600" data-action="load">Oral suspension</a></div>
            <div id="PHP75607"><a href="../medicinalForm/PHP75607.html" data-target="#PHP75607" data-action="load">Powder for solution for infusion</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
